Korman H - Search Results

1

A 17-gene Panel for Prediction of Adverse Prostate Cancer Pathologic Features: Prospective Clinical Validation and Utility.

Eggener S, Karsh LI, Richardson T, Shindel AW, Lu R, Rosenberg S, Goldfischer E, Korman H, Bennett J, Newmark J, Denes BS. Eggener S, et al. Among authors: korman h. Urology. 2019 Apr;126:76-82. doi: 10.1016/j.urology.2018.11.050. Epub 2019 Jan 3. Urology. 2019. PMID: 30611659 Free article.

2

Radical prostatectomy: is complete resection of the seminal vesicles really necessary?

Korman HJ, Watson RB, Civantos F, Block NL, Soloway MS. Korman HJ, et al. J Urol. 1996 Sep;156(3):1081-3. doi: 10.1016/s0022-5347(01)65709-4. J Urol. 1996. PMID: 8709312 Free article.

3

Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications?

Carey JM, Korman HJ. Carey JM, et al. Among authors: korman hj. J Urol. 2001 Jul;166(1):82-5. J Urol. 2001. PMID: 11435829

4

A centralized comparison of radical perineal and retropubic prostatectomy specimens: is there a difference according to the surgical approach?

Korman HJ, Leu PB, Huang RR, Goldstein NS. Korman HJ, et al. J Urol. 2002 Sep;168(3):991-4. doi: 10.1016/S0022-5347(05)64558-2. J Urol. 2002. PMID: 12187206

5

A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.

Vargas C, Ghilezan M, Hollander M, Gustafson G, Korman H, Gonzalez J, Martinez A. Vargas C, et al. Among authors: korman h. J Urol. 2005 Sep;174(3):882-7. doi: 10.1097/01.ju.0000169136.55891.21. J Urol. 2005. PMID: 16093980

6

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.

Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.

7

Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.

Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.

8

Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk Stratification.

Van Neste L, Henao R, Wojno KJ, Signes J, DeHart J, Busta A, Marriott E, Willing M, Argentini A, Hurley PM, Korman H, Hafron J, Putzi M, Pieczonka CM, Karsh LI, Morris DS, Kassis AI, Kantoff PW. Van Neste L, et al. Among authors: korman h. J Urol. 2024 Mar;211(3):415-425. doi: 10.1097/JU.0000000000003824. Epub 2023 Dec 26. J Urol. 2024. PMID: 38147400

9

Intravesical therapy for transitional cell carcinoma of the bladder: the community practice.

Obek C, Shelfo SW, Korman HJ, Soloway MS. Obek C, et al. Among authors: korman hj. Urology. 1999 Jan;53(1):82-7. doi: 10.1016/s0090-4295(98)00446-4. Urology. 1999. PMID: 9886593 Free article. Clinical Trial.

10

Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States.

Messing EM, Teot L, Korman H, Underhill E, Barker E, Stork B, Qian J, Bostwick DG. Messing EM, et al. Among authors: korman h. J Urol. 2005 Oct;174(4 Pt 1):1238-41. doi: 10.1097/01.ju.0000173918.84006.4d. J Urol. 2005. PMID: 16145377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters